{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:06:20Z","timestamp":1775570780474,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,31]]},"DOI":"10.7759\/cureus.102749","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:30:35Z","timestamp":1769916635000},"source":"Crossref","is-referenced-by-count":1,"title":["Deutetrabenazine and Modified Electroconvulsive Therapy for Tardive Dyskinesia With Recurrent Depression: A Case Report"],"prefix":"10.7759","author":[{"given":"Zhiying","family":"Wan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v11.i32.7895","article-title":"Multiple therapies relieve long-term tardive dyskinesia in a patient with chronic schizophrenia: a case report","volume":"11","author":"Lv L","year":"2023","unstructured":"Lv L, Guo P, Feng M, Fang Y, Wang SK, Chen HX. Multiple therapies relieve long-term tardive dyskinesia in a patient with chronic schizophrenia: a case report. World J Clin Cases. 2023, 11:7895-9. 10.12998\/wjcc.v11.i32.7895","journal-title":"World J Clin Cases"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.114538","article-title":"Structural brain changes associated with tardive dyskinesia in schizophrenia","volume":"203","author":"Sarr\u00f3 S","year":"2013","unstructured":"Sarr\u00f3 S, Pomarol-Clotet E, Canales-Rodr\u00edguez EJ, et al.. Structural brain changes associated with tardive dyskinesia in schizophrenia. Br J Psychiatry. 2013, 203:51-7. 10.1192\/bjp.bp.112.114538","journal-title":"Br J Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031844","article-title":"Therapeutic interventions to mitigate mitochondrial dysfunction and oxidative stress-induced damage in patients with bipolar disorder","volume":"23","author":"Madireddy S","year":"2022","unstructured":"Madireddy S, Madireddy S. Therapeutic interventions to mitigate mitochondrial dysfunction and oxidative stress-induced damage in patients with bipolar disorder. Int J Mol Sci. 2022, 23:4. 10.3390\/ijms23031844","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.919272","article-title":"Reduced gray matter volume in orbitofrontal cortex across schizophrenia, major depressive disorder, and bipolar disorder: a comparative imaging study","volume":"16","author":"Yang Y","year":"2022","unstructured":"Yang Y, Li X, Cui Y, et al.. Reduced gray matter volume in orbitofrontal cortex across schizophrenia, major depressive disorder, and bipolar disorder: a comparative imaging study. Front Neurosci. 2022, 16:2. 10.3389\/fnins.2022.919272","journal-title":"Front Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000204.pub2","article-title":"Anticholinergic medication for antipsychotic-induced tardive dyskinesia","volume":"1","author":"Bergman H","year":"2018","unstructured":"Bergman H, Soares-Weiser K. Anticholinergic medication for antipsychotic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2018, 1:CD000204. 10.1002\/14651858.CD000204.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1708\/4487.44874","article-title":"Diagnosis and management of tardive dyskinesia: from research to clinical practice","volume":"60","author":"Fagiolini A","year":"2025","unstructured":"Fagiolini A, Barone P, Bellomo A, et al.. Diagnosis and management of tardive dyskinesia: from research to clinical practice. Riv Psichiatr. 2025, 60:51-60. 10.1708\/4487.44874","journal-title":"Riv Psichiatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000491","article-title":"Antipsychotic-induced tardive dyskinesia: update on epidemiology and management","volume":"32","author":"Widschwendter CG","year":"2019","unstructured":"Widschwendter CG, Hofer A. Antipsychotic-induced tardive dyskinesia: update on epidemiology and management. Curr Opin Psychiatry. 2019, 32:179-84. 10.1097\/YCO.0000000000000491","journal-title":"Curr Opin Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.16091037","article-title":"Kinect 3: a phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia","volume":"174","author":"Hauser RA","year":"2017","unstructured":"Hauser RA, Factor SA, Marder SR, et al.. Kinect 3: a phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia. Am J Psychiatry. 2017, 174:476-84. 10.1176\/appi.ajp.2017.16091037","journal-title":"Am J Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2134","article-title":"Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry","volume":"97","author":"Haring R","year":"2012","unstructured":"Haring R, Hannemann A, John U, et al.. Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab. 2012, 97:408-15. 10.1210\/jc.2011-2134","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of Brief Psychiatric Rating Scale scores","volume":"187","author":"Leucht S","year":"2005","unstructured":"Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale scores. Br J Psychiatry. 2005, 187:366-71. 10.1192\/bjp.187.4.366","journal-title":"Br J Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.04.028","article-title":"Severity classification on the Hamilton Depression Rating Scale","volume":"150","author":"Zimmerman M","year":"2013","unstructured":"Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton Depression Rating Scale. J Affect Disord. 2013, 150:384-8. 10.1016\/j.jad.2013.04.028","journal-title":"J Affect Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0032-x","article-title":"Impaired reward prediction error encoding and striatal-midbrain connectivity in depression","volume":"43","author":"Kumar P","year":"2018","unstructured":"Kumar P, Goer F, Murray L, et al.. Impaired reward prediction error encoding and striatal-midbrain connectivity in depression. Neuropsychopharmacology. 2018, 43:1581-8. 10.1038\/s41386-018-0032-x","journal-title":"Neuropsychopharmacology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.NU18041BR2C","article-title":"Psychosocial implications of tardive dyskinesia in patients with mood disorders versus schizophrenia","volume":"80","author":"McEvoy JP","year":"2019","unstructured":"McEvoy JP. Psychosocial implications of tardive dyskinesia in patients with mood disorders versus schizophrenia. J Clin Psychiatry. 2019, 80:2. 10.4088\/JCP.NU18041BR2C","journal-title":"J Clin Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/02698811221104058","article-title":"Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression","volume":"37","author":"Scott F","year":"2023","unstructured":"Scott F, Hampsey E, Gnanapragasam S, et al.. Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression. J Psychopharmacol. 2023, 37:268-78. 10.1177\/02698811221104058","journal-title":"J Psychopharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115054","article-title":"Benztropine and suicide attempts and intentional self-harm","volume":"320","author":"Gibbons RD","year":"2023","unstructured":"Gibbons RD, Hur K, Lavigne JE, Mann JJ. Benztropine and suicide attempts and intentional self-harm. Psychiatry Res. 2023, 320:4. 10.1016\/j.psychres.2023.115054","journal-title":"Psychiatry Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/2045125314553611","article-title":"Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia","volume":"4","author":"Desmarais JE","year":"2014","unstructured":"Desmarais JE, Beauclair L, Annable L, B\u00e9langer MC, Kolivakis TT, Margolese HC. Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia. Ther Adv Psychopharmacol. 2014, 4:257-67. 10.1177\/2045125314553611","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15244","article-title":"Tardive neurotoxicity of anticholinergic drugs: A review","volume":"158","author":"Marzoughi S","year":"2021","unstructured":"Marzoughi S, Banerjee A, Jutzeler CR, Prado MA, Rosner J, Cragg JJ, Cashman N. Tardive neurotoxicity of anticholinergic drugs: A review. J Neurochem. 2021, 158:1334-44. 10.1111\/jnc.15244","journal-title":"J Neurochem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.11.064","article-title":"Electroconvulsive therapy and age: age-related clinical features and effectiveness in treatment resistant major depressive episode","volume":"227","author":"Socci C","year":"2018","unstructured":"Socci C, Medda P, Toni C, Lattanzi L, Tripodi B, Vannucchi G, Perugi G. Electroconvulsive therapy and age: age-related clinical features and effectiveness in treatment resistant major depressive episode. J Affect Disord. 2018, 227:627-32. 10.1016\/j.jad.2017.11.064","journal-title":"J Affect Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17m11777","article-title":"The effects of valbenazine in participants with tardive dyskinesia: results of the 1-year Kinect 3 extension study","volume":"78","author":"Factor SA","year":"2017","unstructured":"Factor SA, Remington G, Comella CL, et al.. The effects of valbenazine in participants with tardive dyskinesia: results of the 1-year Kinect 3 extension study. J Clin Psychiatry. 2017, 78:1344-50. 10.4088\/JCP.17m11777","journal-title":"J Clin Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.20200034","article-title":"Performance in practice: practice assessment tool for the care of patients with schizophrenia","volume":"18","author":"Fochtmann LJ","year":"2020","unstructured":"Fochtmann LJ, Medicus J, Hong SH. Performance in practice: practice assessment tool for the care of patients with schizophrenia. Focus (Am Psychiatr Publ). 2020, 18:402-23. 10.1176\/appi.focus.20200034","journal-title":"Focus (Am Psychiatr Publ)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/431372-deutetrabenazine-and-modified-electroconvulsive-therapy-for-tardive-dyskinesia-with-recurrent-depression-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:30:47Z","timestamp":1769916647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/431372-deutetrabenazine-and-modified-electroconvulsive-therapy-for-tardive-dyskinesia-with-recurrent-depression-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.102749","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,31]]}}}